Navigation Links
Use of Technology to Document Comorbid Conditions May Improve Reimbursement, Increase Documentation Accuracy Study Confirms
Date:10/10/2007

MOBILE, Ala., Oct. 10 /PRNewswire/ -- Major financial implications are at stake if healthcare facilities and physicians do not accurately record the health conditions of patients that are present on admission (POA), according to new regulations by the Centers for Medicare and Medicaid Services (CMS).

CMS is adjusting the logic for Diagnosis Related Group (DRG) assignment, including new methods for identifying patients who are severely ill (that is, have comorbid illnesses) and consequently warrant higher hospital reimbursement. To quality for this level of reimbursement, these secondary medical conditions must be identified and described in detail on the medical chart.

Recently-published research in the September 2007 Journal of Clinical Outcomes Management showed that concurrent coding utilizing electronic medical record technology can significantly increase the identification and documentation of these comorbid illnesses, which in turn increases the severity of illness and risk of mortality indexes used for reimbursement. The research, titled "Effect of Concurrent Computerized Documentation of Comorbid Conditions on the Risk of Mortality Index", partially relied on coding technology from DocuSys, Inc., a leading anesthesia information management system (AIMS) and medication management system provider.

"The technology provided by DocuSys provides a detailed view of comorbid conditions currently not available with common paper documentation in use by most anesthesia clinicians," said Dr. Jerry Stonemetz, Clinical Associate and Compliance Officer, Anesthesia & Critical Care Medicine, Johns Hopkins University. "This detail could significantly affect the data captured by most hospitals, resulting in improved reporting and documentation of comorbid conditions required by CMS and other organizations for reimbursement."

Documentation of comorbid conditions is a primary element of the DocuSys coding module, which is an embedded component of the company's AIMS application. This technology was developed specifically for anesthesiologists who traditionally see a large subset of hospital inpatients with varied medical conditions. It precisely captures a patient's existing medical conditions while assigning ICD-9 diagnosis codes to them. In the study, concurrent coding using this technology increased severity of illness and risk of mortality ratings by 16 percent and 17 percent respectively.

Accurate identification of comorbid conditions has been a challenge for healthcare providers that has only been recently addressed with technology, according to Dr. Peter Pronovost, Professor and Medical Director of the Center for Innovations in Quality Patient Care at Johns Hopkins Medical Institute and University School of Medicine. "Documenting comorbid conditions and consistent use of that data among healthcare providers has been challenging," he said. "Technological solutions to assist with identification of comorbidity have numerous benefits that include developing medical care plans specific to each patient which improves the probability of receiving correct payment from CMS. Also, with patient safety and quality measure reporting currently at the forefront of the healthcare industry, precise documentation of each case has never been more important."

About DocuSys

DocuSys is a market-leading anesthesia information management system (AIMS) and medication management system provider, maximizing both the quality of care and return on investment in surgery. The system incorporates customizable decision support, professional fee capture, comorbid condition documentation and an intravenous medication management application, which uses barcoding and digital imaging to automate documentation, tracking and billing of medication. DocuSys' modular design permits integration with existing hospital information systems, electronic drug dispensing cabinets, infusion pumps, physiologic monitors and other systems in those settings where intravenous medication delivery is key. http://www.docusys.net.

Contact: Tom Mitchell, Director of Marketing Communications

email: tmitchell@docusys.net

phone: (251) 461-9903, ext. 133


'/>"/>
SOURCE DocuSys
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Vedic vibration technology- the new cure for arthritis
2. Biotechnology industry expected to grow into a three billion dollar industry by 2002
3. Biotechnology on the lead
4. New Technology In MRI Scan Help Test Brain Cancer Therapy
5. New technology to decipher neural connections dealing with heredity and environment
6. Emergence Of New Gene Scanning Technology In Disease Research
7. CoQ10 bioavailability increased by Nanotechnology
8. Developing a new vaccine using a new technology
9. Scientists Develop New Technology To Find About Human Ancestors’ Teet
10. T-waves to sweep over imaging technology
11. Nanotechnology Revolution To Be Spearheaded By European Union
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... Boulder, CO (PRWEB) , ... April 25, 2017 ... ... Law and Liberty attempts to compare student test score performance for the 2015-16 ... one of the state’s voucher programs. Though it highlights important patterns in student ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients ... that achieves results in a fraction of the time as traditional braces – ... Significance Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
(Date:4/25/2017)... , ... April 25, 2017 , ... Back Pain ... and back pain with a reputable physician in their area, announces the launch of ... patient information for patients who are looking for reputable physicians to help them with ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, ... to its patient care management module. Using this new feature, sleep physicians can ... been initiated on continuous positive airway pressure (CPAP), oral, or other forms of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
Breaking Medicine News(10 mins):
(Date:4/25/2017)... Endo International plc (NASDAQ: ENDP ) will announce its ... management team will host a conference call and webcast before the ... The dial-in number to access the call is U.S./ Canada ... 6086379. Please dial in 10 minutes prior to the scheduled start ... call will be available from May 9, 2017 at 11:30 a.m. ...
(Date:4/24/2017)... BOURNEMOUTH, England , April 24, 2017 /PRNewswire/ ... line development, today announced the addition of a ... for ,Validated In-situ Plate Seeding,). The VIPS has ... 96 and 384 well microplates as part of ... new system offers a simple and more reliable ...
(Date:4/20/2017)... MINNEAPOLIS , April 20, 2017  Cogentix ... company focused on providing the Urology, Uro/Gyn and ... reported that Ash Keswani has joined the Company ... In this newly created position, Mr. Keswani will ... and CEO. "Our organization is delighted ...
Breaking Medicine Technology: